Trial Profile
A Randomized, Double-blind, Placebo-controlled Multiple Dosing Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream After Transdermal Administration in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs Asivatrep (Primary)
- Indications Atopic dermatitis; Pruritus; Rosacea; Seborrhoeic dermatitis; Skin disorders
- Focus Adverse reactions
- Sponsors AmorePacific
- 10 Jan 2017 New trial record